Bengaluru: Aster DM Healthcare, launched three personalised initiatives for cancer care: Precision Oncology Clinics; Aster Cancer Grid; and Onco Collect by the Dr Ramesh Nimmegadda Cancer Foundation.
The newly launched initiatives aim to offer personalised, data-driven, and research-based treatments, emphasising genomic approaches to improve patient outcomes and deliver cutting-edge cancer therapies.
The Precision Oncology Clinics will focus on cancer care aligned with the genomic profile of the patient. While, the second program Aster Cancer Grid will enable collaborative research, and multi-center clinical trials and standardise cancer care. In addition, it will aggregate data from all Aster Hospitals and will indulge in joint funding applications, grant opportunities and funded research initiatives in cancer.
Lastly, the Onco Collect Software by Dr Ramesh Nimmegadda Cancer Foundation will provide a platform to standardise practice management by placing all patient data in one location, creating a uniform database and providing outcome analysis thus ensuring evidence-based treatment by clinicians.
Dr. C N Patil, HOD and Lead Consultant – Medical Oncology & Haemato-Oncology, Aster Whitefield Hospital, commented, “India’s prowess is software and it is the ideal setting to drive health and cancer care in particular through software driven data analysis that would ensure greater automation and hence accuracy in understanding cancer dynamics. Software ensures reliability that may escape human intervention at times although a combination of both is the perfect strategy to guarantee against errors in treatment methodologies. The right balance will surely generate a successful outcome.”
“This collective effort aims to establish India as a global leader in cancer research and treatment through cutting-edge innovation and strategic partnerships. By collaborating with world-renowned oncologists, researchers, research institutions, and leading pharma and biotech companies, we are accelerating the development and implementation of innovative therapies and interventions in cancer care,” added Dr Azad Moopen, Founder & Chairman, Aster DM Healthcare.
